Description
RADIOPHARMACEUTICALS
First action · last action
2010-01-28 · 2010-10-01
Transactions
2
First transaction's obligation
$278,715
Base + all options value (sum of deltas)
$1,254,218
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-01-28+$278,715= $278,715
- Mod 12010-10-01+$418,073= $696,788
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-01-28 | +$278,715 | $278,715 | RADIOPHARMACEUTICALS |
| Mod 1· EXERCISE AN OPTION | 2010-10-01 | +$418,073 | $696,788 | RADIOPHARMACEUTICALS |
Related awards · 10
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GY8NMUZQXVS7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926P0013 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $358,454 | FY2026 |
| 36C25926N0074 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $435,690 | FY2026 |
| 36C25925P0724 | NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $35,984 | FY2025 |
| 36C24E25C0002 | RPO EAST (36C24E) · AJ14 · GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES | $39,502 | FY2025 |
| 36C25925N0026 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $429,877 | FY2025 |
| 36C26224P1817 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · R410 · SUPPORT- PROFESSIONAL: PROGRAM EVALUATION/REVIEW/DEVELOPMENT | $24,950 | FY2024 |
Other recipients under Q517 from 635-OKLAHOMA CITY (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613P0101 | HERITAGE HEALTH SOLUTIONS, INC. | 635-OKLAHOMA CITY | $72,000 | FY2013 |
| VA25612P0161 | HERITAGE HEALTH SOLUTIONS, INC. | 635-OKLAHOMA CITY | $34,000 | FY2012 |
| VA635C05188 | HERITAGE HEALTH SOLUTIONS, LP | 635-OKLAHOMA CITY | $12,500 | FY2010 |
| VA635Q97674 | HERITAGE HEALTH SOLUTIONS, LP | 635-OKLAHOMA CITY | $0 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA256P0854_3600_-NONE-_-NONE- · retrieved 2026-09-26.